TP53 missense mutation is associated with increased tumor-infiltrating T cells in primary prostate cancer.
Kaur HB, Lu J, Guedes LB, Maldonado L, Reitz L, Barber JR, De Marzo AM, Tomlins SA, Sfanos KS, Eisenberger M, Schaeffer EM, Joshu CE, Lotan TL.
Kaur HB, et al. Among authors: lu j.
Hum Pathol. 2019 May;87:95-102. doi: 10.1016/j.humpath.2019.02.006. Epub 2019 Mar 6.
Hum Pathol. 2019.
PMID: 30851334
Free PMC article.